miR-10a and miR-204 as a Potential Prognostic Indicator in Low-Grade Gliomas

This study aimed to identify and characterize microRNAs (miRNAs) that are related to radiosensitivity in low-grade gliomas (LGGs). The miRNA expression levels in radiosensitive and radioresistant LGGs were compared using The Cancer Genome Atlas database, and differentially expressed miRNAs were identified using the EBSeq package. The miRNA target genes were predicted using Web databases. Fifteen miRNAs were differentially expressed between the groups, with miR-10a and miR-204 being related to overall survival (OS) of patients with LGG. Patients with upregulated miR-10a expression had a higher mortality rate and shorter OS time, whereas patients with downregulated miR-204 expression had a lower mortality rate and longer OS time. Two genes, HSP90AA1 and CREB5, were targets for both miRNAs. Thus, this study suggests that expression of miR-10a and miR-204 is significantly related to both radiosensitivity and the survival of patients with LGG. These miRNAs could therefore act as clinical biomarkers for LGG prognosis and diagnosis.

[1]  R. Barnard,et al.  The classification of tumours of the central nervous system. , 1982, Neuropathology and applied neurobiology.

[2]  L. Recht,et al.  Expression of bcl-2 in reactive and neoplastic astrocytes: lack of correlation with presence or degree of malignancy. , 1995, Journal of neurosurgery.

[3]  G. Baretton,et al.  Apoptosis and immunohistochemical bcl‐2 expression in colorectal adenomas and carcinomas: Aspects of carcinogenesis and prognostic significance , 1996, Cancer.

[4]  H. Moch,et al.  Prognostic significance of Bcl-2 in clinically localized prostate cancer. , 1996, The American journal of pathology.

[5]  O. Kallioniemi,et al.  Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. , 2000, Cancer research.

[6]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[7]  S. Nakasu,et al.  bcl-2 protein expression in tumors of the central nervous system , 2004, Acta Neuropathologica.

[8]  M. Piérart,et al.  Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial , 2005, The Lancet.

[9]  Tara L. Naylor,et al.  microRNAs exhibit high frequency genomic alterations in human cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[10]  E. Livingston,et al.  Colon cancer and apoptosis. , 2006, American journal of surgery.

[11]  D. Ellison,et al.  Clinical and molecular characteristics of malignant transformation of low-grade glioma in children. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[13]  Bob Löwenberg,et al.  MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. , 2008, Blood.

[14]  C. Croce.  Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.

[15]  Tongbin Li,et al.  miRecords: an integrated resource for microRNA–target interactions , 2008, Nucleic Acids Res..

[16]  Xiaohua Li,et al.  Survival prediction of gastric cancer by a seven-microRNA signature , 2009, Gut.

[17]  M. Lerch,et al.  Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. , 2009, Gastroenterology.

[18]  V. Bardou,et al.  Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancer. , 2009, Surgical oncology.

[19]  Chih-Hao Chang,et al.  microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma. , 2010, Cancer research.

[20]  Mark Gerstein,et al.  Network Modeling Identifies Molecular Functions Targeted by miR-204 to Suppress Head and Neck Tumor Metastasis , 2010, PLoS Comput. Biol..

[21]  Chi-Ying F. Huang,et al.  miRTarBase: a database curates experimentally validated microRNA–target interactions , 2010, Nucleic Acids Res..

[22]  Bryan Kolb,et al.  Sex-specific radiation-induced microRNAome responses in the hippocampus, cerebellum and frontal cortex in a mouse model. , 2011, Mutation research.

[23]  I. Nakano,et al.  Glioma stem cells: their role in chemoresistance. , 2012, World neurosurgery.

[24]  Xijie Yu,et al.  MicroRNA-204 critically regulates carcinogenesis in malignant peripheral nerve sheath tumors. , 2012, Neuro-oncology.

[25]  O. Slabý,et al.  MicroRNAs involved in chemo- and radioresistance of high-grade gliomas , 2013, Tumor Biology.

[26]  F. Slack,et al.  MicroRNAs in the ionizing radiation response and in radiotherapy. , 2013, Current opinion in genetics & development.

[27]  Jueheng Wu,et al.  Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype. , 2013, Cancer research.

[28]  Hua Jin,et al.  Decreased Expression of miR216a Contributes to Non–Small-Cell Lung Cancer Progression , 2014, Clinical Cancer Research.

[29]  Yuan Yin,et al.  miR-204-5p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB22A , 2014, Clinical Cancer Research.

[30]  Guangzhi Wang,et al.  miR-122/Wnt/β-catenin regulatory circuitry sustains glioma progression , 2014, Tumor Biology.

[31]  E. Yengil,et al.  miR-204-5p expression in colorectal cancer: an autophagy-associated gene , 2014, Tumor Biology.

[32]  Qing Liu,et al.  miR-135b Contributes to the Radioresistance by Targeting GSK3β in Human Glioblastoma Multiforme Cells , 2014, PloS one.

[33]  Ming Yao,et al.  MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN , 2015, Oncotarget.

[34]  A. Carvalho,et al.  Expression of miR-296-5p as predictive marker for radiotherapy resistance in early-stage laryngeal carcinoma , 2015, Journal of Translational Medicine.